Hong Kong Beverage Stock News

Tencent Holdings (SEHK:700) is back in focus after Tencent Mobility moved to sell up to $1.55b in Kuaishou shares, alongside AI product adjustments prompted by new Chinese regulations on companion chatbots. See our latest analysis for Tencent Holdings. The HK$452.0 share price has seen short term momentum pick up, with a 1 day share price return of 4.82% and 7 day gain of 7.57%. This comes even though the year to date share price return is down 27.45% and the 3 year total shareholder return...

China Taiping Insurance Holdings (SEHK:966) has drawn fresh investor attention after shareholders approved a final dividend of HK$1.23 per share for 2025 at the company’s annual general meeting on 24 June 2026. See our latest analysis for China Taiping Insurance Holdings. Alongside the approved HK$1.23 per share final dividend, China Taiping Insurance Holdings has seen its share price move to HK$20.52, with a 1 day share price return of 3.90% and a 7 day share price return of 10.80%, while...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Last week, Far East Hotels and Entertainment Limited ( HKG:37 ) insiders, who had purchased shares in the previous 12...

As global markets navigate mixed economic signals, including a cooling U.S. labor market and resilient manufacturing activity in China, investors are increasingly exploring diverse opportunities across regions. Penny stocks, while often seen as a relic of past market eras, continue to represent an intriguing investment area due to their potential for growth at lower price points. By focusing on those with solid financials and promising prospects, investors can uncover hidden gems among...

Wasion Holdings (SEHK:3393) drew investor attention after its Mexican subsidiary secured the Federal Electricity Commission’s 2026 smart meter tender, with potential orders above RMB695 million and implications for overseas revenue stability. See our latest analysis for Wasion Holdings. At the current share price of HK$21.86, Wasion Holdings has seen a sharp 10.85% 1 day share price return and a 21.58% year to date share price return. The 1 year total shareholder return is 156.99%, indicating...

CSPC Pharmaceutical Group (SEHK:1093) is back in focus after a new collaboration, option and license agreement with AstraZeneca to develop siRNA based renal disease treatments using CSPC’s AI enabled nucleic acid drug platforms. See our latest analysis for CSPC Pharmaceutical Group. Those R&D updates and the AstraZeneca collaboration come as CSPC Pharmaceutical Group’s share price has climbed 15.10% over the past week, yet remains down 15.24% over three months. The 3 year total shareholder...

Why the Haihzu land win matters for Yuexiu Property Yuexiu Property (SEHK:123) has drawn investor attention after its unit secured a land parcel in Guangzhou's Haihzu District, a move tied directly to the company's property development and investment pipeline in Mainland China. See our latest analysis for Yuexiu Property. At a share price of HK$3.62, Yuexiu Property has seen short term momentum pick up, with a 1 day share price return of 1.97% and a 7 day gain of 7.42%. However, the 30 day...

Oil markets are being pulled in several directions at once as China’s crude demand softens, OPEC+ increases quotas, and Russian and Iranian barrels build up at sea. That mix creates pressure for some companies and potential openings for others tied to production, refining, storage, and tanker activity. For investors, the key question is which stocks look more exposed to weaker pricing power and which might see steadier demand for moving or holding crude. This article walks through three...

3SBio (SEHK:1530) drew investor attention after its 25 June 2026 AGM, where shareholders approved a final dividend of HK$0.25 per share and appointed KPMG as auditor, replacing EY. See our latest analysis for 3SBio. The AGM decisions came after a volatile year for 3SBio, with the share price delivering a 24.04% gain over 30 days but still down 20.87% year to date. The 5 year total shareholder return of 155.61% contrasts with a 20.14% decline over the past 12 months. If 3SBio's recent moves...

China Gas Holdings (SEHK:384) has highlighted weaker full year results and a reduced shareholder payout, reporting lower revenue and net income alongside a proposed cut in its final dividend for FY2026. See our latest analysis for China Gas Holdings. Despite the dividend cut news giving the stock a short-term lift, with a 1-day and 7-day share price return of 2.39%, China Gas Holdings has seen its momentum fade, with the 30-day share price return down 20.66% and the 1-year total shareholder...

As global markets navigate a mixed landscape, with major U.S. indices like the Nasdaq Composite and S&P 500 showing gains while small-cap indices such as the Russell 2000 decline, investors are closely monitoring economic indicators that suggest a cooling labor market and subdued consumer confidence. In this environment, characterized by fluctuating treasury yields and varying sector performances, identifying high-growth tech stocks requires a focus on companies that demonstrate resilience...

As global markets navigate a mixed economic landscape, with key indices like the Nasdaq Composite and S&P 500 showing gains while small-cap benchmarks such as the Russell 2000 face declines, investors are closely monitoring shifts in labor market dynamics and consumer confidence. Amidst these fluctuations, discovering stocks that stand out due to strong fundamentals or unique market positions can be particularly rewarding; these "undiscovered gems" often possess resilient business models or...

Ascletis Pharma (SEHK:1672) recently received U.S. FDA Investigational New Drug clearance to begin a Phase I trial of ASC35, a once monthly GLP-1R/GIPR dual agonist for obesity treatment. See our latest analysis for Ascletis Pharma. At a latest share price of HK$11.54, Ascletis Pharma has seen a 7 day share price return of 18.72% and a 30 day share price return of 10.11%. However, the 90 day share price return is down 32.04%. The 1 year total shareholder return of 22.51% and the very large 3...

Citi’s upgrade of Chervon Holdings (SEHK:2285) has drawn fresh attention to the stock, with investors weighing the reassessment alongside routine board and company secretary changes announced in late June. See our latest analysis for Chervon Holdings. The Citi upgrade appears to have coincided with a sharp shift in sentiment, with Chervon Holdings posting a 1-day share price return of 6.96% and a 30-day share price return of 34.92%. The 1-year total shareholder return of 37.44% contrasts with...

As global markets experience mixed performances, with the U.S. labor market showing signs of cooling and China's manufacturing activity indicating resilience, investors are closely watching the Asian tech sector for high-growth opportunities. In this environment, a good stock in the high-growth tech space is often characterized by strong fundamentals and adaptability to shifting economic conditions, making Damai Entertainment Holdings a notable player in Asia's dynamic market landscape.

As of July 2026, Asian markets are navigating a complex landscape shaped by mixed economic signals and sector rotations. Amid these evolving conditions, investors are increasingly exploring opportunities in lesser-known segments of the market. Penny stocks, though an outdated term, still capture the essence of investing in smaller or emerging companies that can offer significant value when backed by strong financials and growth potential.

China’s latest clampdown on its $3.4 trillion private tech fund industry is reshaping where capital can flow, who controls it, and how much risk sits on public balance sheets. For investors, that creates a split screen: some stocks face tighter funding channels and heightened regulatory attention, while others outside this ecosystem may find less aggressive Chinese competition in global markets. This article unpacks how that news filters through to 3 individual stocks exposed to these shifts,...

COSCO SHIPPING Energy Transportation (SEHK:1138) has drawn fresh attention after confirming a 2025 final dividend of RMB 0.38 per share and moving the H share payment date forward to 25 August 2026. See our latest analysis for COSCO SHIPPING Energy Transportation. Alongside the confirmed dividend and recent board changes, COSCO SHIPPING Energy Transportation’s share price sits at HK$14.55, with a 1 day share price return of 5.51% and year to date share price return of 50.47%. The 1 year total...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

China International Capital Corporation Limited has approved a final cash dividend of RMB 2.3 per 10 shares (HK$2.644632 per 10 shares) for the year ended 31 December 2025, with shareholder approval obtained on 26 June 2026 and payment scheduled for 24 August 2026. This higher final cash dividend highlights how the firm is prioritising direct cash returns to shareholders at this stage of its capital allocation. Next, we will examine how this higher final cash dividend shapes China...

As of July 2026, Asian markets are experiencing a mixed environment, with China's manufacturing activity showing resilience and Japan's financial sectors benefiting from improved business sentiment. In this context, identifying small-cap stocks that demonstrate strong fundamentals and insider activity can be crucial for navigating the evolving economic landscape.

As Asian markets navigate a period of mixed performance, with China's manufacturing activity showing resilience and Japan's business sentiment improving, investors are keenly observing opportunities that may be flying under the radar. In such an environment, identifying undervalued stocks requires a keen understanding of market dynamics and the ability to recognize companies with strong fundamentals that may not yet be fully appreciated by the broader market.

As global markets navigate mixed economic signals, including cooling labor markets in the U.S. and resilient manufacturing activity in China, investors are increasingly turning their attention to small-cap stocks for potential growth opportunities. In this context, identifying promising companies like Beijing Chunlizhengda Medical Instruments can be crucial; these undiscovered gems often offer unique value propositions that align well with evolving market dynamics and investor sentiment.